학술논문
Alternating therapy with osimertinib and afatinib for treatment-naive patients with EGFR-mutated advanced non-small cell lung cancer: A single-group, open-label phase 2 trial (WJOG10818L)
Document Type
Article
Author
Hayashi, Hidetoshi; Yonesaka, Kimio; Nakamura, Atsushi; Fujimoto, Daichi; Azuma, Koichi; Sakata, Shinya; Tachihara, Motoko; Ikeda, Satoshi; Yokoyama, Toshihide; Hataji, Osamu; Yano, Yukihiro; Hirano, Katsuya; Daga, Haruko; Okada, Hideaki; Chiba, Yasutaka; Sakai, Kazuko; Nishio, Kazuto; Yamamoto, Nobuyuki; Nakagawa, Kazuhiko
Source
In Lung Cancer June 2022 168:38-45
Subject
Language
ISSN
0169-5002